Global Protein Therapeutics Market 2012-2016

Global Protein Therapeutics Market 2012-2016

Category : Healthcare

TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Protein Therapeutics market to grow at a CAGR of 7.08 percent over the period 2012–2016. One of the key factors contributing to this market growth is the increasing prevalence of chronic diseases. The market has also been witnessing increasing outsourcing of drug development. However, patent-expiration of top-selling drugs could pose a challenge to the growth of this market. 
TechNavio's report, the Global Protein Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Global Protein Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Roche Holding Ltd., Amgen Inc., Abbott Laboratories, J&J, and Novo Nordisk A/S.
The other vendors mentioned in this report are AstraZeneca plc, Biogen Idec Inc., Eli Lilly and Co., Novartis International AG, Bristol Myers Squibb Co., Merck & Co. Inc., Pfizer Inc., Curis Inc., UCB S.A., Elan Corporations Plc, Human Genome Sciences Inc., Daiichi Sankyo Co. Ltd., and GlaxoSmithKline plc.
Key questions answered in this report:
What will the market size be in 2015 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Research Methodology


Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

Product Offerings

06. Market Landscape

06.1 Market Size and Forecast

Market Segmentation

06.2 Global Monoclonal Antibodies market

Market Size and Forecast

Market Segmentation

Top Monoclonal Antibodies Drugs

06.3 Global Insulin Market

Market Segmentation

Top Insulin Drugs

06.4 Global Erythropoietin Market

Market Size and Forecast

06.5 Five Forces Analysis

07. Geographical Segmentation

08. Vendor Landscape


08.1 Global Protein Therapeutics Market

08.2 Global Monoclonal Antibodies Market

08.3 Global Insulin Market

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Key Vendor Analysis


15.1 Abbott Laboratories

Business Overview

Key Information

SWOT Analysis

15.2 Amgen Inc.

Business Overview

Key Information

SWOT Analysis

15.3 Roche Holding Ltd.

Business Overview

Key Information

SWOT Analysis

15.4 Johnson & Johnson

Business Overview

Key Information

SWOT Analysis

15.5 Novo Nordisk A/S

Business Overview

Key Information

SWOT Analysis

16. Other Reports in this Series



List of Exhibits:

Exhibit 1: Market Research Methodology

Exhibit 2: Global Protein Therapeutics Market 2012-2016 (US$ billion)

Exhibit 3: Global Protein Therapeutics Market Segmentation

Exhibit 4: Global Protein Therapeutics Market Segmentation 2012

Exhibit 5: Global Monoclonal Antibodies Market 2012–2016 (US$ billion)

Exhibit 6: Global Monoclonal Antibodies Market Segmentation Based on Application

Exhibit 7: Global Monoclonal Antibodies Market Segmentation 2011

Exhibit 8: Top Drugs in the Global Monoclonal Antibodies Market 2012(US$ billion)

Exhibit 9: Top Drugs in Global Monoclonal Antibodies Market 2012 (percentage)

Exhibit 10: Global Insulin Market 2012–2016 (US$ billion)

Exhibit 11: Global Insulin Market Segmentation

Exhibit 12: Global Insulin Market Segmentation 2012

Exhibit 13: Top Drugs in the Global Monoclonal Antibodies Market 2012(US$ billion)

Exhibit 14: Top Drugs in Global Monoclonal Antibodies Market 2012 (percentage)

Exhibit 15: Global Erythropoietin Market 2012–2016 (US$ billion)

Exhibit 16: Global Protein Therapeutics Market by Geographical Segmentation 2012

Exhibit 17: Global Protein Therapeutics Market by Vendor Segmentation 2012

Exhibit 18: Global Monoclonal Antibodies Market by Vendor Segmentation 2012

Exhibit 19: Global Insulin Market by Vendor Segmentation 2012

Exhibit 20: Business Segmentation of Abbott Laboratories

Exhibit 21: Business Segmentation of Roche Holding Ltd.

Exhibit 22: Business Segmentation of Johnson & Johnson

Exhibit 23: Business Segmentation of Novo Nordisk A/S



Enquiry Before Buy